4//SEC Filing
Boulding Mark Elliott 4
Accession 0001578852-26-000004
CIK 0001070081other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:20 PM ET
Size
25.2 KB
Accession
0001578852-26-000004
Insider Transaction Report
Form 4
Boulding Mark Elliott
EXEC. VP AND CLO
Transactions
- Sale
Common Stock
2026-01-06$76.95/sh−1,739$133,816→ 119,162 total - Sale
Common Stock
2026-01-07$77.48/sh−1,503$116,452→ 117,659 total - Exercise/Conversion
Common Stock
2026-01-07$38.10/sh+2,625$100,013→ 120,284 total - Sale
Common Stock
2026-01-07$77.11/sh−1,638$126,306→ 118,646 total - Sale
Common Stock
2026-01-07$77.91/sh−949$73,937→ 117,697 total - Sale
Common Stock
2026-01-07$78.60/sh−38$2,987→ 117,659 total - Exercise/Conversion
Common Stock
2026-01-07$38.10/sh+751$28,613→ 118,410 total - Sale
Common Stock
2026-01-07$77.10/sh−471$36,314→ 117,939 total - Sale
Common Stock
2026-01-07$77.92/sh−269$20,960→ 117,670 total - Sale
Common Stock
2026-01-07$78.98/sh−11$869→ 117,659 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-07−2,625→ 751 totalExercise: $38.10Exp: 2032-01-06→ Common Stock (2,627 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-07−751→ 0 totalExercise: $38.10Exp: 2032-01-06→ Common Stock (751 underlying)
Footnotes (8)
- [F1]Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a January 3, 2025 grant of 18,000 RSUs.
- [F2]Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.
- [F3]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.
- [F4]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.56 to $77.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.58 to $78.54 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.54 to $77.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F7]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.54 to $78.47 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F8]Currently exercisable.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001578852
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 5:20 PM ET
- Size
- 25.2 KB